April 2012
- LRG mourns the loss of a great friend, Jeroen Pit
- GDOL Update: Speakers announced
- LRG Research Team meets in Leuven, Belgium: leaves with renewed energy & commitment to finding the cure for GIST
- Meet our new Montana local rep: Dirk Niebaum
- Cellular origin of GIST from the “good” cells’ perspective
- Alianza GIST meets in Miami
- And they’re off! 1st ‘Harness a Cure’ is a success
- NJ GIST gathering serves up support & smoothies
- NoCal GISTers meet!
- New report finds most hospital errors go unreported
- Happy Cancerversary to Brenda Bannon!
- Thomas G. Overley, 1952-2012: Toledo lawyer played guitar, sang in group
- Durham lived life with passion and pride
- Did You Hear? Did You Know?
- Arizona GISTers meet!
- Spunky Texan fought GIST bravely
- Calendar
Archive
June 2008
June 2008 clinical trials update
AMN107 Phase III:
This trial has met accrual goals and enrollment is now closed.
Sunitinib or Imatinib:
Five new sites have been added in the United States. Four new international sites have also been added:
1. Lai Chi Kok, Kowloon, Hong Kong
2. Tuen Mun, New Territories, Hong Kong
3. Milano, Italy, 20133,
4. Seoul, Republic of Korea, 135-710
Imatinib + Pegylated Interferon-a 2B:
This trial now has an NCT number and the contact information has changed. Contact Jessica Moehle, 801-587-4438 at the Huntsman Cancer Institute.
Sorafenib Phase II:
Contact information has been updated. Perifosine + Sunitinib: Trial is ongoing but not recruiting.
To view the latest clinical trials, visit: http://www.liferaftgroup.org/docs/gist_clinical_trial_datasheets.htm
0 Comments